CRNX - Crinetics Pharmaceuticals GAAP EPS of -$0.78 beats by $0.03 revenue of $0.46M beats by $0.26M November, 14 2022 09:14 AM Crinetics Pharmaceuticals Inc. Crinetics Pharmaceuticals press release ( NASDAQ: CRNX ): Q3 GAAP EPS of -$0.78 beats by $0.03 . Revenue of $0.46M beats by $0.26M . For further details see: Crinetics Pharmaceuticals GAAP EPS of -$0.78 beats by $0.03, revenue of $0.46M beats by $0.26M